CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's EPS Net Growth by Quarter and Year

Atara Biotherapeutics,'s EPS Net results by quarter and year




ATRA EPS Net (in $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - -1.15 -0.63 -
III Quarter September - -1.02 -0.88 -0.43
II Quarter June -1.15 -0.94 -0.66 -0.62
I Quarter March -1.05 -0.88 -0.58 -0.42
FY   -2.20 -3.99 -2.75 -1.47



ATRA EPS Net second quarter 2018 Y/Y Growth Comment
Atara Biotherapeutics, Inc. in the second quarter recorded EPS net loss of $ -1.15 .

According to the results reported in the second quarter, Atara Biotherapeutics, Inc. achieved the best EPS Net growth in Biotechnology & Drugs industry. While Atara Biotherapeutics, Inc.' s EPS Net no change of % ranks overall at the positon no. in the second quarter.




ATRA EPS Net ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics,'s second quarter 2018 EPS Net $ -1.15 ATRA's Income Statement
Atara Biotherapeutics,'s second quarter 2017 EPS Net $ -0.94 Quarterly ATRA's Income Statement
New: More ATRA's historic EPS Net Growth >>


ATRA EPS Net (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net second quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net second quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2015, 2016, 2017, 2018
You need to upgrade your Flash Player

Atara Biotherapeutics,'s Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's II. Quarter Q/Q EPS Net Comment
Recent results of -1.15 by Atara Biotherapeutics, Inc. appear even more unfavourable considering the EPS net loss -1.05 in the first quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential EPS Net growth. While Atara Biotherapeutics,'s EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's II. Quarter Q/Q EPS Net Comment
Recent results of -1.15 by Atara Biotherapeutics, Inc. look even worse compare to the EPS net loss -1.05 a quarter before.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential EPS Net growth. While Atara Biotherapeutics,'s EPS Net growth quarter on quarter, overall rank is .


Atara Biotherapeutics,'s 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
12 Months Ending
(Jun 30 2017)
Cumulative EPS Net 12 Months Ending $ -4.37 $ -4.16 $ -3.99 $ -3.47 $ -3.33
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months EPS net loss of $ -4 in the Jun 30 2018 period.
The business is getting worse as the cumulative EPS net loss is becoming larger from $ -4.16 for the period from Mar 31 2018 to Jun 30 2017 and $ -1.05 for the twelve months ending in the quarter a year ago Marietta Rossi wrote.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months EPS net loss of $ -4 in the Jun 30 2018 period.
The business is worsening as the cumulative EPS net loss is inflating from $ -4.16 for the period from Mar 31 2018 to Jun 30 2017 and $ -1.05 for the twelve months ending in the quarter Jun 30 2017 Marietta Rossi mentioned.

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


You need to upgrade your Flash Player




Other EPS Net Growth
Biotechnology & Drugs Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
ATRA's EPS Net Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for ATRA's Competitors
EPS Net Growth for Atara Biotherapeutics,'s Suppliers
EPS Net Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Jun 30 2018 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Jun 30 2018
Petmed Express Inc  37.78 %$ 37.778 
Conmed Corp  36.36 %$ 36.364 
Hca Healthcare, Inc.  32.00 %$ 32.000 
Encompass Health Corp  31.43 %$ 31.429 
Baxter International Inc  31.25 %$ 31.250 
Psychemedics Corp  31.25 %$ 31.250 
Civitas Solutions, Inc.  30.00 %$ 30.000 
Idexx Laboratories Inc  29.47 %$ 29.474 
Lifepoint Health, Inc.  29.13 %$ 29.126 
Bio-techne Corp  26.12 %$ 26.123 
Laboratory Corp Of America Holdings  24.73 %$ 24.725 
Mednax, Inc.  23.19 %$ 23.188 
U S Physical Therapy Inc  23.08 %$ 23.077 
Steris Plc  20.59 %$ 20.588 
Amgen Inc.  19.59 %$ 19.588 
Acadia Healthcare Company, Inc.  17.54 %$ 17.544 
Electromed, Inc.  16.99 %$ 16.987 
Healthcare Services Group Inc  16.67 %$ 16.667 
China Yct International Group, Inc.  15.38 %$ 15.385 
Steadymed Ltd.  15.15 %$ 15.152 
Mettler Toledo International Inc  12.24 %$ 12.240 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PRAN's Profile

Stock Price

PRAN's Financials

Business Description

Fundamentals

Charts & Quotes

PRAN's News

Suppliers

PRAN's Competitors

Customers & Markets

Economic Indicators

PRAN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071